# SCVC

> SCVC is a VC fund in Bristol backing Biotechnology and Hardware. See 34 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: Bristol, United Kingdom
- Total investments: 34
- Last investment: Jul 2026
- Lead investor: 53%
- Last fund: Sep 2023
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company/sc-vc
- X (Twitter): https://twitter.com/SCVC_UK
- Website: https://sciencecreates.co.uk/ventures/

SCVC is a leading UK emerging manager, focused on early-stage deep tech start-ups spinning out of the UK's world-leading academic institutions. Building the VC firm they wished they had as founders, the SCVC team’s mission is to create global impact for the health of people and the planet, via partnering with exceptional technical foundersleveraging deep tech. SCVC is comprised of distinguished exited innovators, scientists & engineers who have backed multiple deep tech spin-outs. SCVC is the official venture arm of Science Creates (SC); leveraging this renowned UK ecosystem that has already incubated over 100 startups. We invest in advanced technologies from biotech to quantum tech, partnering with companies aligned with our mission of improving the health of people and the planet. We’re a team of deep tech nerds and serial entrepreneurs that backs like-minded founders wanting to change the world. We are the official VC arm of Science Creates. Being part of Science Creates plugs you into an ecosystem of specialist Incubators, Investment, Partners and Programmes, all designed and curated for deep tech start-ups.We are building the VC firm we wished we had as founders.

## Contacts

5 contacts available for SCVC. Shizune tracks 5 team members at SCVC. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/science-creates-ventures?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Biotechnology | 5 | 15% |
| Hardware | 2 | 6% |
| Life Science | 2 | 6% |
| Therapeutics | 2 | 6% |
| Manufacturing | 2 | 6% |

24 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Seed | 10 | 29% |
| Pre-Seed | 4 | 12% |
| Funding Round | 4 | 12% |
| Series A | 1 | 3% |

### Country

| Country | Investments | Share |
| --- | --- | --- |
| United Kingdom | 14 | 41% |
| United States | 1 | 3% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Catherine Fletcher | Principal | 1 | https://shizune.co/investors/profile/catherine-fletcher-cd63 |
| Harry Destecroix | Co-Founder and Managing Partner | 13 | https://shizune.co/investors/profile/harry-destecroix-02f0 |
| Harry Destecroix | Co-Founder and Managing Partner | 10 | https://shizune.co/investors/profile/harry-destecroix |
| John Williams | Partner | 3 | https://shizune.co/investors/profile/john-williams-2ef3 |
| Laura Davies | Investment Manager | 0 | https://shizune.co/investors/profile/laura-davies-222a |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Pixel-Flo | Pixel-Flo is developing a fluidic self-assembly mass transfer process that uses a slot-die mechanism and meniscus forces to continuously position microLEDs onto substrates. This backplane-agnostic technology is designed to assemble red, green, and blue LEDs in a single step for mass-market display manufacturing. | $7M | Seed | Jul 09, 2026 |  |
| Houdini Bio | Houdini Bio develops computational synthetic biology tools that redesign DNA sequences and gene constructs for more effective genetic medicines. The company focuses on re-engineering and optimizing DNA constructs to address performance and scalability constraints in complex therapeutics. Its technology applies computational biology methods toimprove expression characteristics and manufacturing properties of genetic medicine assets. Houdini Bio works with partners developing next-generation genetic therapies who seek to enhance therapeutic index and production output. Its core offering centers on a DNA redesign engine that enables systematic exploration of sequence space to generate constructs with improved functional profiles. The company positions its capabilities for use in biopharmaceutical research and development workflows for genetic medicines. Houdini Bio concentrates on supporting organizations working on advanced genetic therapeutics that require improved construct design and manufacturability. | $1.9M | Pre-Seed | Jun 19, 2026 |  |
| Scarlet Therapeutics | Scarlet Therapeutics is developing the novel red blood cell-based therapeutics (tRBCs) generation platform. | $4.4M | Seed | May 07, 2026 |  |
| Delta g | Delta g is a gravity sensing hardware and technology development company that has developed a cutting-edge underground imaging system that leverages quantum technology. It is a spinout from the University of Birmingham. | $6.2M | Seed | Sep 26, 2025 |  |
| Delta g | Delta g is a gravity sensing hardware and technology development company that has developed a cutting-edge underground imaging system that leverages quantum technology. It is a spinout from the University of Birmingham. | $6.2M | Seed | Sep 26, 2025 |  |
| PhovIR Technologies | PhovIR Technologies is a deep-tech firm that specializes in miniaturized near-infrared (NIR) material analytics. | $5.4M | Seed | Aug 19, 2025 |  |
| Portal Biotech | Portal Biotech is a biotechnology company specializing in advanced proteomics and metabolomics through single-molecule detection. | $37.1M | Series A | Jun 30, 2025 |  |
| Zero Point Motion | Zero Point Motion uses optical sensing techniques called 'cavity optomechanics’ for chip sensors to improve navigation and stabilization. | $5.2M | Seed | Mar 13, 2025 |  |
| Zero Point Motion | Zero Point Motion uses optical sensing techniques called 'cavity optomechanics’ for chip sensors to improve navigation and stabilization. | $5.2M | Seed | Mar 13, 2025 |  |
| Theo Ai | THEO AI operates as a legal prediction engine to forecast the outcome of legal dispute. | $2.2M | Pre-Seed | Nov 20, 2024 |  |

10 of 34 investments shown.

## Co-investors
- [Foresight WAE Technology](https://shizune.co/investors/profile/foresight-wae-technology) — VC Fund, 5 deals together
- [Broadview Ventures](https://shizune.co/investors/profile/broadview-ventures) — VC Fund, 4 deals together
- [Business Growth Fund](https://shizune.co/investors/profile/business-growth-fund) — VC Fund, 4 deals together
- [Foresight Group](https://shizune.co/investors/profile/foresight-group) — VC Fund, 4 deals together
- [Meltwind Advisory](https://shizune.co/investors/profile/meltwind-advisory) — VC Fund, 4 deals together
- [Parkwalk Advisors](https://shizune.co/investors/profile/parkwalk-advisors) — VC Fund, 4 deals together

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

## FAQ

### What does SCVC invest in?

SCVC invests primarily in Biotechnology, Hardware and Life Science startups, most often at Seed and Pre-Seed stage. Most of the 34 investments tracked by Shizune back companies in United Kingdom. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact SCVC?

Public channels for SCVC include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at SCVC?

The team at SCVC includes Catherine Fletcher (Principal), Harry Destecroix (Co-Founder and Managing Partner) and Harry Destecroix (Co-Founder and Managing Partner). The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co